Workshop Overview
Stomach cancer, also known as gastric cancer, is an important public health concern that requires greater awareness of its risk factors, symptoms, diagnostic methods and treatment options. Early clinical evaluation and appropriate diagnostic investigations are essential for identifying the disease and planning effective care.
BioGenesis Health Cluster proposes to organise a specialised Stomach Cancer Awareness, Early Diagnosis and Clinical Demonstration Workshop as part of the 8th Global Cancer Summit 2027 in Aizawl, Mizoram.
Led by an experienced gastroenterologist, surgical oncologist, medical oncologist or cancer scientist, the workshop will combine expert lectures, anatomical demonstrations, illustrative diagnostic cases and interactive scientific discussions.
The programme will bring together clinicians, surgeons, oncologists, researchers, medical students, healthcare workers, NGOs and members of the general public to improve understanding of stomach cancer risk factors, warning signs, diagnostic procedures, treatment pathways and advances in cancer research.
With particular attention to the cancer burden and healthcare needs of Northeast India, the workshop aims to promote public awareness, encourage timely medical consultation and strengthen collaboration between healthcare institutions, research organisations and community groups.
Through scientific education and practical demonstrations, BioGenesis Health Cluster seeks to bridge the gap between research, clinical practice and community awareness.
Scientific programme and demonstrations
Session 1 — Understanding Stomach Cancer
Introduction to stomach anatomy, types of gastric cancer, relevant risk factors and the importance of recognising persistent digestive symptoms.
Session 2 — Risk Factors and Warning Signs
Discussion of Helicobacter pylori infection, tobacco use, family history, selected dietary risk factors and symptoms such as persistent upper abdominal discomfort, unexplained weight loss, difficulty swallowing, early fullness or evidence of gastrointestinal bleeding.
Session 3 — Diagnostic Demonstration
Educational presentation of upper gastrointestinal endoscopy, stomach biopsy, histopathological examination and the role of imaging and staging investigations. Use anonymised clinical images or simulation equipment where appropriate.
Session 4 — Cancer Research and Scientific Advances
Discussion of gastric cancer biology, tumour classification, molecular biomarkers, H. pylori prevention and treatment, and developments in precision oncology and targeted therapies.
Session 5 — Treatment and Comprehensive Patient Care
Overview of surgery, chemotherapy, selected targeted and immunotherapies, nutritional support, rehabilitation and palliative care, according to the disease stage and individual clinical circumstances.
Session 6 — Public Awareness and Expert Interaction
Interactive discussion on reducing risk, recognising warning signs, accessing diagnostic services and understanding when specialist medical advice is needed.
Intended participants
- Clinicians, gastroenterologists and oncologists
- Clinical assessment, endoscopic diagnosis, pathology and treatment planning.
- Scientists and research scholars
- Gastric cancer biology, molecular research, biomarkers and translational science.
- Medical students and healthcare workers
- Cancer awareness, symptom recognition, referral and patient education.
- Men, families, NGOs and the general public
- Understanding risk factors, recognising persistent symptoms and seeking timely medical evaluation.
Expected learning outcomes
- Improved understanding of stomach cancer risk factors and warning signs.
- Greater awareness of the role of endoscopy and biopsy in diagnosis.
- Better understanding of the relationship between H. pylori infection and gastric cancer.
- Exposure to developments in pathology, molecular research and treatment.
- Stronger collaboration among clinicians, scientists, hospitals and medical colleges.
- Improved public awareness of appropriate medical evaluation and cancer care services in Northeast India.
Suggested workshop arrangements
| Component |
Recommended format |
| Duration |
2-3 hours |
| Lead faculty |
Experienced gastroenterologist, oncologist or cancer scientist |
| Demonstration |
Anatomical model, endoscopy images, pathology slides or simulation |
| Scientific discussion |
Clinicians, surgeons, pathologists and researchers |
| Public interaction |
Expert question-and-answer session |
| Learning material |
Illustrated handouts on risk factors, warning signs and diagnostic pathways |
All demonstrations should be conducted using approved teaching materials, simulation equipment or properly anonymised clinical cases. Any live clinical procedure must follow institutional safety, consent and privacy requirements.